2Biswas SK,Zhao Y-Nagalingam A,et al. PDGF-and insulin/ IGF-1 -specific distinct modes of class IA PI 3-kinase activation in nor- real rat retinas and RGC-5 retinal ganglion cells. Invest Ophthalmol Vis Sci 2008;49:3687 - 3698.
6K/DOQI. Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007 ;49(suppl 2) :S1 - S178.
8Cingel-Ristic V, Flyvbjerg A, Drop SL. The physiological and pathophysiological roles of the GH/IGF-axis in the kidney : Lessons from experimental rodent models. Growth Horm IGF Res, 2004,14:418.
9Wang Y, Halley J, Williams D, et al. Inhibition of insulin-like growth factor-1 receptor (IGF-1R) signaling and tumor cell growth by a fully human neutralizing anti-IGF-1R antibody. Mol Cancer Ther ,2005,4 : 1214-1221.
10Epa VC, Ward CW. Model for the complex between the insulin- like growth factor 1 and its receptor: towards designing antagonists for the IGF-1 receptor. Protein Eng Des Sel,2006,19:377- 384.
4HAQUE N,SAl.MA U,NURUNNABI T R,et al.Management of type2 diabetes mellitus by lifestyle,diet and medicinal plants[J].Pak J Biol Sci,2011,14(1):13-24.
5PENICKA M,BARTUNEK J,DE BRUYNE B,et al.Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography[J].Circulation,2004,109(8):978-983.
6RUBLER S,DLUGASH J,YUCEOGLU Y Z,et al.New type of cardiomyopathy associated with diabetic glomerulosclerosis[J].Am J Cardiol,1972,30(6):595-602.
7HAMBY R I,ZONERAICH S,SHERMAN L.Diabetic cardiomyopathy[J].JAMA,1974,229(13):1749-1754.
9GOYAL B R,MEHTA A A.Diabetic cardiomyopathy:pathophysiological mechanisms and cardiac dysfuntion[J].Hum Exp Toxicol,2013,32(6):571-590.
10VON BIBRA H,ST JOHN SUTTON M.Diastolic dysfunction in diabetes and the metabolic syndrome:promising potential for diagnosis and prognosis[J].Diabetologia,2010,53(6):1033-1045.
